Add SMA to Newborn Screening in Scotland, Experts in Country Say
A group of healthcare professionals involved in the diagnosis and care of people with spinal muscular atrophy (SMA) in…
Articles by Marta Figueiredo, PhD
New DNA Reference Map May Aid in Identifying SMN1 Mutations
A research team in the U.S. has developed a new DNA reference, or benchmark, map with detailed sequence information on…
Evrysdi Soon Available at Low or No Cost to SMA Patients in Scotland
The Scottish Medicines Consortium (SMC) has added oral Evrysdi (risdiplam) to the list of medications available through the country’s National Health…
Untreated Woman with SMA Type 3 Gives Birth to Two Healthy Children
Note: This story was updated Feb. 14, 2022, to clarify that this was a case of two successful pregnancies…
Targeted NGS Seen as Best When Screening for SMA and Its Carriers
Targeted next generation sequencing (NGS) — a powerful genetic method that can identify mutations in several genes simultaneously — is…
Despite Taking Spinraza, SMA Type 1 Children Show Nonmotor Problems
Despite its well-reported benefits in motor function, Spinraza (nusinersen) may not be as effective at preventing or easing nonmotor…
US Medical Data Show Higher Mortality in SMA Patients Before DMT Era
Before the emergence of Spinraza (nusinersen) — the first disease-modifying therapy (DMT) approved for spinal muscular atrophy (SMA) —…
Family History Can Be Key in Identifying Silent Carriers of SMA
A family and medical history examination was crucial in the genetic counseling given a 28-year-old pregnant woman with two previous…
Top 10 SMA Stories of 2021
SMA News Today brought you daily coverage of the latest scientific findings, treatment developments, and clinical trials related to spinal muscular…
Spine Surgery Effective in SMA Type 1 Children, But Not Without Risks
Surgery to correct kyphoscoliosis — a combination of two types of abnormal curvature of the spine — allows the successful…